Related references
Note: Only part of the references are listed.Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease
Andrea C. Paula-Lima et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β
Robert M. Koffie et al.
BRAIN (2012)
Cyclin-Dependent Kinase 5 Activator p25 Is Generated During Memory Formation and Is Reduced at an Early Stage in Alzheimer's Disease
Olivia Engmann et al.
BIOLOGICAL PSYCHIATRY (2011)
Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition
Olivia Engmann et al.
BRAIN (2011)
Neurotoxicity of beta-Amyloid Protein: Oligomerization, Channel Formation and Calcium Dyshomeostasis
Masahiro Kawahara
CURRENT PHARMACEUTICAL DESIGN (2010)
Comparison of a Protein-Level and Peptide-Level Labeling Strategy for Quantitative Proteomics of Synaptosomes Using Isobaric Tags
Olivia Engmann et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Jorge J. Palop et al.
NATURE NEUROSCIENCE (2010)
Synaptic degeneration in Alzheimer's disease
Thomas Arendt
ACTA NEUROPATHOLOGICA (2009)
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Xinglong Wang et al.
JOURNAL OF NEUROSCIENCE (2009)
Crosstalk between Cdk5 and GSK3 beta: implications for Alzheimer's disease
Olivia Engmann et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2009)
Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3β mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing
Yi Wen et al.
JOURNAL OF NEUROSCIENCE (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Role of septin cytoskeleton in spine morphogenesis and dendrite development in neurons
Tomoko Tada et al.
CURRENT BIOLOGY (2007)
The GTP-binding protein septin 7 is critical for dendrite branching and dendritic-spine morphology
Yunli Xie et al.
CURRENT BIOLOGY (2007)
Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory
Marco Angelo et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation
Florian Plattner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory
A Fischer et al.
NEURON (2005)
Is there a role of the cyclin-dependent kinase 5 activator p25 in Alzheimer's disease?
KP Giese et al.
NEUROREPORT (2005)
Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death
MJ O'Hare et al.
JOURNAL OF NEUROSCIENCE (2005)
Sexual dimorphisms in the effect of low-level p25 expression on synaptic plasticity and memory
L Ris et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
OPA1 requires mitofusin 1 to promote mitochondrial fusion
S Cipolat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles
A Tandon et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Improved reversal learning and altered fear conditioning in transgenic mice with regionally restricted p25 expression
M Angelo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains
HC Tseng et al.
FEBS LETTERS (2002)
Neurobiology - p25 protein in neurodegeneration
BC Yoo et al.
NATURE (2001)
Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains
S Taniguchi et al.
FEBS LETTERS (2001)
Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25
G Kusakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)